Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group.

In 1985 a second randomisation was initiated for women in the treatment arm of the Scottish Tamoxifen Trial either to stop tamoxifen at 5 years or to continue indefinitely. A preliminary analysis of outcome in 342 patients at a median follow-up of 6 years suggests that a worthwhile gain in disease c...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, H. J., Forrest, A. P., Everington, D., McDonald, C. C., Dewar, J. A., Hawkins, R. A., Prescott, R. J., George, W. D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074573/
https://www.ncbi.nlm.nih.gov/pubmed/8688340

Ejemplares similares

Ejemplares similares